MedPath

Temoporfin

Generic Name
Temoporfin
Brand Names
Foscan
Drug Type
Small Molecule
Chemical Formula
C44H32N4O4
CAS Number
122341-38-2
Unique Ingredient Identifier
FU21S769PF

Overview

Temoporfin is a photosensitizing agent used in the treatment of squamous cell carcinoma of the head and neck . It was first authorized for market by the European Medicines Agency in October 2001. It is currently available under the brand name Foscan.

Background

Temoporfin is a photosensitizing agent used in the treatment of squamous cell carcinoma of the head and neck . It was first authorized for market by the European Medicines Agency in October 2001. It is currently available under the brand name Foscan.

Indication

For use in the treatment of patients with advanced squamous cell carcinoma of the head and neck failing standard therapies and who are unsuitable for radiotherapy, surgery, or systemic chemotherapy .

Associated Conditions

  • Advanced squamous cell carcinoma of the head and neck

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath